SCHEMBL20157973

SCHEMBL20157973

CNS(=O)(=O)Cc1ccc(C(=O)c2ccc(C)cc2)c(Br)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.42
MAPT P10636 3/20 0.42
NPC1 O15118 2/20 0.39
HTT P42858 2/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
CA2 P00918 1/20 0.37
KDM5A P29375 1/20 0.37
AKR1C3 P42330 1/20 0.37
ALKBH5 Q6P6C2 1/20 0.37
RAB9A P51151 2/20 0.37
GAA P10253 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CCR9 P51686 1/20 0.36
RXRA P19793 1/20 0.36
EGFR P00533 1/20 0.36
ERBB2 P04626 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157951 0.86 MAPT (0.47) SRD5A2MAPTNPC1HTTMAPK1
SCHEMBL20157342 0.85 SRD5A2 (0.43) SRD5A2MAPTNPC1HTTMAPK1
SCHEMBL20157960 0.80 SRD5A2 (0.49) SRD5A2MAPTNPC1HTTMAPK1
SCHEMBL20157469 0.79 POLB (0.47) SRD5A2MAPTNPC1HTTMAPK1
SCHEMBL20157976 0.78 MAPT (0.49) SRD5A2MAPTNPC1HTTMAPK1
SCHEMBL21362472 0.75 SRD5A2 (0.43) SRD5A2MAPTNPC1HTTMAPK1
SCHEMBL20157557 0.75 PTPN1 (0.39) MAPTHTTALDH1A1LMNACA2
SCHEMBL9046172 0.74 GAA (0.48) ALDH1A1LMNACA2ALKBH5GAA
SCHEMBL20157815 0.74 KMT2A (0.40) SRD5A2MAPTNPC1ALDH1A1LMNA
SCHEMBL20157579 0.74 TP53 (0.38) MAPTHTTMAPK1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018086605-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF 山东罗欣药业集团股份有限公司 2018-05-17 WO disclosed